Quanterix announced this week it has appointed Paul Chapman as its new president and CEO, replacing Martin Madaus, who will continue at the company as executive chairman.
Chapman was previously vice president of EMD Millipore's BioPharm Processing Solutions business. Before that he was vice president of hospital solutions for Roche Near Patient Testing in Austria.
Biodesix this week appointed Dominic Spinella vice president of clinical development and medical affairs.
Spinella was previously executive director and head of translational and molecular medicine for Pfizer's biotherapeutics division. Prior to that he was head of translational medicine for Pfizer Oncology as well as vice president of exploratory research at Chugai Pharmaceuticals.
Opko Health has appointed Juan Rodriguez as senior vice president and chief financial officer.
Rodriguez was previously a consultant to software firm Cognitec Systems. Before that he held a number of executive positions at Kos Pharmaceuticals, which was acquired in 2007 by Abbott Laboratories.